Is there a regional solution to vaccine inequity?
Regionally-based vaccine manufacturing networks can provide the scale and agility needed to combat vaccine inequity that germinated out of the pandemic.
He has served as Ambassador for Global Health at Norway’s Ministry of Foreign Affairs. He was founding Chief Executive Officer of CEPI (Coalition for Epidemic Preparedness Innovations) and has been CEO, Research Council of Norway; Executive Director, Infection Control and Environmental Health, Norwegian Institute of Public Health; founding Chief Executive, Norwegian Knowledge Centre for the Health Services; Professor of Health Policy, Institute of Health and Society, University of Oslo; Professor of Global Health and Population, Harvard T.H. Chan School of Public Health; Visiting Fellow of Practice at Blavatnik School of Government, Oxford University. He has been Norway Oxford Scholar at Wadham College; Fulbright Fellow at Harvard Kennedy School; Chair of the Board of the Alliance for Health Policy and Systems Research; board member of Gavi, PATH, Medicines Patent Pool and GARDP; chair of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), WHO; co-chair of the Future of the Global Health Initiatives; chair of the ACT-Accelerator Financing Working Group; and member of the G20 High Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response. He is member of the Norwegian Academy of Science and Letters and international member of the US National Academy of Medicine. He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University, and was awarded H.M. the King’s Gold Medal for his doctoral dissertation.
Regionally-based vaccine manufacturing networks can provide the scale and agility needed to combat vaccine inequity that germinated out of the pandemic.
Collaboration is needed between pharmaceutical companies and governments to accelerate equitable global access to COVID-19 tests, treatments and vaccines.